Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
1995-06-05
2010-10-19
Zeman, Mary K (Department: 1631)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C424S184100, C424S186100, C424S188100, C424S192100, C424S204100, C424S207100, C435S005000, C435S007100, C435S069100, C435S069300, C435S320100, C536S023100, C536S023720, C536S024300, C536S024330, C530S350000
Reexamination Certificate
active
07815916
ABSTRACT:
The determination of the nucleotide sequence of HTLV-III DNA; identification, isolation and expression of HTLV-III sequences which encode immunoreactive polypeptides by recombinant DNA methods and production of viral RNA are disclosed. Such polypeptides can be employed in immunoassays to detect HTLV-III.
REFERENCES:
patent: 4520113 (1985-05-01), Gallo
patent: 4689398 (1987-08-01), Wu
patent: 4708818 (1987-11-01), Montagnier
patent: 4716102 (1987-12-01), Levy
patent: 4725669 (1988-02-01), Essex
patent: 4743678 (1988-05-01), Essex
patent: 5135864 (1992-08-01), Montagnier
patent: 5156949 (1992-10-01), Luciw et al.
patent: 5173400 (1992-12-01), Montagnier
Anilonis, A., et al., Structure of the glycoprotein gene in rabies virus.Nature294: 275-278 (1981).
Arya, S.K., et al., Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.Science225:927-929 (1984).
Ghrayeb, J., et al., Secretion cloning vectors inEscherichia coli, Embo J., 3:2437-2442 (1984).
Gray, M.R., et al., Open reading frame cloning: Identification, cloning, and expression of open reading frame DNA,Proc. Nat'l Acad. Sci. USA79: 6598-6602 (1982).
Hahn, B.H., et al. Molecular cloning and characterization of the HTLV-III virus associated with AIDS.Nature312:166-169 (1984).
Kalyanaraman, V.S., et al., Antibodies to the core protein of lymphadenopathy associated virus (LAV) in patients with AIDS.Science225:321-323 (1984).
Kiyokawa, T., et al., Envelope proteins of human T-cell leukemia virus.Proc.Nat'l.Acad.Sci.USA81 6202-6206 (1984).
Montagnier, L., et al., Adaptation of Lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.Science, 225: 63-66 (1984).
Ratner, L., et al. Complete nucleotide sequence of the AIDS virus, HTLV-III.Nature313:277-284 (1985).
Ruther, U., et al., Easy identification of cDNA clones,EMBO J., 2:1791-1794 (1983).
Safai, B., et al., Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.The Lancet, 1438-1440 (1984).
Sarngadharan, M.G., et al., Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.Science224:506-508 (1984).
Schupbach, J., et al., Serological Analysis of a subgroup of human T-Lymphotropic retroviruses (HTLV-III) associated with AIDS.Science224:503-505 (1984).
Seiki, M., et al., Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.Proc Nat'l Acad Sci USA80: 3618-22 (1983).
Shaw, G.M., et al. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome.Science226: 1165-1171 (1984).
Suggs, S.V., et al., Use of synthetic oligonucleotides as hybridization probes: Isolation of cloned cDNA sequences for human B2-microglobulin.Proc Nat'l Acad Sci USA78:6613-17 (1981).
Weinstock, G.M., et al., Open reading frame expression vectors: A general method for antigen production inEscherichia coliusing protein fusions to B-galactosidase.Proc Nat'l Acad Sci USA80: 4432-36 (1983).
Chiron Corporationv.Abbott Laboratories, 902 F.Supp. 1103, 1130 (N.D.Cal. 1995).
Declaration of John A.T. Young, Ph.D. (Declaration Exhibit 1 LUCIW, Interference No. 103,659).
Expert Report of Robin A. Weiss, Ph.D., dated Apr. 17, 1995 (Declaration Exhibit 46 LUCIW, Interference No. 103,659).
Declaration of Robin A. Weiss, Ph.D., dated Feb. 15, 1996 (Declaration Exhibit 2 LUCIW, Interference No. 103,659).
Declaration of William Robinson, M.D. (Declaration Exhibit 3 LUCIW, Interference No. 103,659).
Chang Nancy T.
Gallo Robert C.
Wong-Staal Flossie
Ruppert Siegfried J. W.
The United States of America as represented by the Secretary of
Townsend and Townsend / and Crew LLP
Zeman Mary K
LandOfFree
Cloning and expression of HTLV-III DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloning and expression of HTLV-III DNA, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and expression of HTLV-III DNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178988